INCYTE CORP (INCY)

NASDAQ — Healthcare: Services, Biotechnology: Services-Commercial Physical & Biological Research

www.incyte.com

Upcoming Events

May 30, 2025, 8:21:00 PM

2025 ASCO Annual Meeting Presentation

Incyte will present multiple abstracts featuring new data from its oncology portfolio at the 2025 ASCO Annual Meeting in Chicago, showcasing advancements in cancer therapies.

conference talk
May 30, 2025, 8:21:00 PM

Pemigatinib Phase 2 Study Results Presentation

Results from a Phase 2 study of Pemigatinib for pre-treated glioblastoma will be presented on May 30, 2025, at the ASCO Annual Meeting.

clinical readout
May 31, 2025, 2:00:00 PM

Retifanlimab Patient Experience Presentation

Incyte will present findings on patients with HIV and squamous cell carcinoma treated with Retifanlimab on May 31, 2025, at ASCO.

clinical readout
Jun 1, 2025, 2:00:00 PM

Final Results of POD1UM-201 Study Presentation

Final results from the Phase 2 study of Retifanlimab in advanced Merkel cell carcinoma will be presented on June 1, 2025, at ASCO.

clinical readout
Jun 3, 2025, 1:42:00 PM

INCB123667 Oral Presentation at ASCO

Incyte will present safety and preliminary efficacy data from a Phase 1 study of INCB123667 in patients with advanced platinum-resistant ovarian cancer on June 3, 2025.

clinical readout